MOA of CCR4 antagonost in Development by FLX Bio. Shows combination treatment of CCR4 Antagonist and checkpoint inhibitors to reduce tumor size.
Keywords: Animation, 3D, Video, Advertising / Marketing, Multimedia, Web, Product Demonstration, Biotechnology, Oncology
FLX BIO